Glossary

Tier 1 = fundamental; Tier 2 = important; Tier 3 = specialist

A. Anatomy and Anatomical Directions

Anterior (Tier 2) Toward the front of the body. The anterior surface of the thigh is the front of the thigh. Opposite of posterior.

Anterior horn cells (Tier 2) The nerve cell bodies of the lower motor neurons, located in the front portion of the spinal cord's grey matter. Damage to these cells causes lower motor neuron denervation.

Axon (Tier 1) The long, slender fibre extending from a nerve cell body that carries electrical signals to its target — a muscle, another nerve cell, or a gland. A single motor neuron's axon may extend from the spinal cord to a muscle in the foot, a distance of up to one metre.

Basal lamina (Tier 3) A thin sheet of proteins that surrounds each muscle fibre, providing structural support. During nerve regeneration, the basal lamina tubes left behind after nerve degeneration serve as physical guides for regrowing axons.

Bony prominences (Tier 3) Points where bone lies close to the skin surface with little overlying soft tissue, such as the sitting bones, the base of the spine, and the heels. These areas are particularly vulnerable to pressure ulcers.

Brachial plexus (Tier 1) A network of nerves formed from the spinal nerve roots of the neck (C5–T1) that provides the entire nerve supply to the shoulder, arm, and hand. Injuries to the brachial plexus can result from trauma, traction during birth, or surgery.

Buccinator (Tier 3) A muscle of the cheek, used in blowing and chewing. One of the small, interlocking facial muscles relevant to facial palsy assessment and electrode placement.

Cauda equina (Tier 1) The bundle of spinal nerve roots that descends from the end of the spinal cord (at roughly the first lumbar vertebra) through the lower spinal canal. Damage to the cauda equina causes lower motor neuron denervation of the muscles supplied by those nerve roots, including the legs, bladder, and bowel.

Common peroneal nerve (Tier 3) A branch of the sciatic nerve that wraps around the head of the fibula (the smaller bone of the lower leg). It is vulnerable to compression or injury at this point, and damage causes foot drop — the inability to lift the foot during walking.

Conus medullaris (Tier 1) The tapered lower end of the spinal cord, located at approximately the level of the first lumbar vertebra (L1). Injuries at or below this level damage the lower motor neurons directly, producing denervation of the muscles they supply.

Deltoid (Tier 3) The large triangular muscle covering the shoulder joint, responsible for lifting the arm away from the body. Commonly affected in brachial plexus injuries.

Descending tracts (Tier 2) The nerve fibre pathways that carry signals downward from the brain through the spinal cord to the lower motor neurons. Damage to descending tracts causes upper motor neuron paralysis, in which the lower motor neurons remain intact but lose the instructions from the brain.

Distal (Tier 1) Further from the centre of the body or from the point of origin. The hand is distal to the elbow. Opposite of proximal.

Fascicles (nerve) (Tier 2) Bundles of individual nerve fibres grouped together within a peripheral nerve, each wrapped in its own connective tissue sheath. A single peripheral nerve may contain many fascicles, and different fascicles within the same nerve may carry signals to different muscles.

Gastrocnemius (Tier 3) The larger of the two main calf muscles, forming the visible bulge at the back of the lower leg. Together with the soleus, it is responsible for pointing the foot downward.

Geniculate ganglion (Tier 3) A cluster of nerve cell bodies located within the bony canal of the facial nerve inside the skull. The ganglion is the site where the varicella-zoster virus (the cause of chickenpox and shingles) can reactivate, producing Ramsay Hunt syndrome.

Gluteal muscles (Tier 2) The group of three muscles forming the buttock — the gluteus maximus, medius, and minimus. They are responsible for hip extension, stabilisation, and the maintenance of tissue bulk over the sitting bones.

Hamstrings (Tier 2) The group of three muscles at the back of the thigh, responsible for bending the knee and extending the hip. Commonly denervated in spinal cord injuries affecting the lower motor neurons.

Intratemporal course (Tier 3) The portion of the facial nerve that passes through a bony canal within the temporal bone of the skull. This canal is narrow and inflexible, which means that any swelling of the nerve within it can cause compression and further nerve damage.

Ischial tuberosities (Tier 3) The bony projections at the base of the pelvis — commonly known as the sitting bones. In a seated position, body weight is concentrated over these structures, making the overlying tissue vulnerable to pressure ulcers, particularly when the protective muscle bulk has been lost through denervation.

Orbicularis oculi (Tier 3) The circular muscle surrounding the eye, responsible for closing the eyelid. Paralysis of this muscle in facial palsy prevents complete eye closure, risking damage to the cornea.

Orbicularis oris (Tier 3) The circular muscle surrounding the mouth, responsible for pursing and closing the lips. Its paralysis in facial palsy affects eating, drinking, and speech.

Peripheral nerve (Tier 1) A nerve outside the brain and spinal cord. Peripheral nerves carry motor signals from the spinal cord to muscles, sensory signals from the body back to the spinal cord, and autonomic signals that regulate blood vessels, sweat glands, and other involuntary functions.

Posterior (Tier 2) Toward the back of the body. The posterior surface of the thigh is the back of the thigh. Opposite of anterior.

Proximal (Tier 1) Closer to the centre of the body or to the point of origin. The shoulder is proximal to the elbow. Opposite of distal.

Quadriceps (Tier 2) The group of four muscles on the front of the thigh, responsible for straightening the knee. The quadriceps are the most extensively studied muscles in the denervated muscle stimulation research.

Sciatic nerve (Tier 3) The largest nerve in the body, running from the lower spine through the buttock and down the back of the leg. It supplies most of the muscles of the lower limb and can be damaged by spinal cord injury, hip surgery, or direct trauma.

Soleus (Tier 3) A broad, flat calf muscle lying beneath the gastrocnemius, important for standing and walking. Together with the gastrocnemius, it forms the calf muscle group.

Subcutaneous tissue (Tier 3) The layer of tissue lying immediately beneath the skin, consisting mainly of fat and connective tissue. Electrical current must pass through this layer to reach the underlying muscle.

Tibialis anterior (Tier 3) The muscle on the front of the lower leg, responsible for lifting the foot upward (dorsiflexion). Its denervation causes foot drop.

B. Physiology and Cellular Biology

Actin (Tier 3) A protein that forms the thin filaments of the muscle's contractile machinery. During contraction, myosin (the thick filaments) pulls on actin filaments, causing the muscle fibre to shorten.

Adipose tissue (Tier 3) Fat tissue. In the context of denervated muscle, adipose tissue progressively replaces functional muscle fibres — a process that, beyond a certain point, becomes irreversible.

Aerobic metabolism (Tier 3) The process by which cells generate energy using oxygen. Slow-twitch (Type I) muscle fibres rely primarily on aerobic metabolism, making them resistant to fatigue.

Anaerobic metabolism / glycolysis (Tier 2) Energy production without oxygen, relying instead on the rapid breakdown of glucose. Fast-twitch (Type IIx) muscle fibres depend on anaerobic glycolysis, producing powerful contractions that fatigue quickly.

Atrophy (Tier 1) The wasting or shrinkage of a tissue. Muscle atrophy following denervation involves both a reduction in the size of individual muscle fibres and, eventually, a loss of fibres altogether as they are replaced by fat and scar tissue.

Collagen (Tier 2) A structural protein that forms the main component of connective tissue, tendons, and scar tissue. In denervated muscle, collagen progressively replaces functional muscle fibres, contributing to fibrosis.

Contractile proteins / apparatus (Tier 2) The proteins within a muscle fibre — principally actin and myosin — that interact to produce contraction. In denervated muscle, these proteins are progressively degraded and disorganised.

Depolarisation (Tier 1) A change in the electrical charge across a cell membrane, making the inside of the cell less negative. In nerve and muscle cells, depolarisation beyond a critical threshold triggers an action potential — the electrical signal that initiates nerve conduction or muscle contraction. Depolarisation is the fundamental event that electrical stimulation seeks to produce.

Fat infiltration (Tier 1) The progressive replacement of functional muscle tissue by fat. In denervated muscle, fat infiltration begins within months and, if unchecked, eventually renders the muscle incapable of contraction even if the nerve supply is restored.

Fibrosis / fibrotic (Tier 1) The replacement of functional tissue by scar tissue (collagen). In denervated muscle, fibrosis accompanies fat infiltration, progressively stiffening the tissue and reducing its capacity to contract. Once established, fibrosis is largely irreversible.

Ion channels (Tier 2) Protein structures in cell membranes that allow specific charged particles (ions) to pass through in a controlled manner. Sodium channels, for example, open during depolarisation to allow sodium ions into the cell, generating the action potential. In denervated muscle, changes in ion channel distribution and behaviour alter the tissue's electrical properties.

Mesenchymal cells (Tier 3) A type of connective tissue cell found within muscle. In the context of denervation, mesenchymal cells called fibro-adipogenic progenitors can differentiate into fat or scar tissue cells, contributing to the replacement of muscle with non-functional tissue.

Myelin / myelin sheath (Tier 1) An insulating layer of fatty material that wraps around nerve fibres (axons), produced by Schwann cells in peripheral nerves. Myelin dramatically increases the speed of electrical signal conduction along the nerve. Damage to the myelin sheath (demyelination) slows or blocks nerve signals.

Myofibril (Tier 2) One of the many thread-like contractile structures within a muscle fibre, composed of repeating units called sarcomeres. Loss of myofibril density is a hallmark of denervation atrophy; its restoration is a key indicator of successful treatment.

Myoglobin (Tier 3) An oxygen-storing protein found in muscle fibres, particularly abundant in slow-twitch (Type I) fibres. Myoglobin gives these fibres their red colour and supports sustained aerobic activity.

Myosin (Tier 3) A protein that forms the thick filaments of the muscle's contractile machinery. Different forms of myosin (myosin heavy chain isoforms) characterise different muscle fibre types.

Myosin heavy chain isoforms (Tier 2) Different molecular forms of the myosin protein that determine the contractile properties of a muscle fibre. The specific isoform expressed determines whether a fibre is slow-twitch (Type I), fast fatigue-resistant (Type IIa), or fast fatigable (Type IIx). Denervation causes a shift toward faster, more fatigable isoforms.

Nuclei (in cellular context) (Tier 3) The control centres of cells, containing the genetic material (DNA) that directs protein production. Muscle fibres are unusual in having multiple nuclei per fibre, reflecting their formation by the fusion of many precursor cells during development.

Reinnervation (Tier 1) The process by which a regrowing nerve fibre re-establishes a functional connection with a muscle that has lost its nerve supply. Successful reinnervation restores the muscle's ability to contract voluntarily and in response to standard electrical stimulation. The success of reinnervation depends on the severity of nerve injury, the distance the nerve must regrow, and the condition of the muscle at the time the nerve arrives.

Sarcomere (Tier 3) The basic contractile unit of a muscle fibre — a precisely ordered arrangement of actin and myosin filaments that shortens when the muscle contracts. Thousands of sarcomeres arranged in series along each myofibril produce the overall shortening of the muscle.

Satellite cells (Tier 1) The resident stem cells of skeletal muscle, located between the muscle fibre membrane and the surrounding basal lamina. Normally dormant, satellite cells are activated in response to injury or exercise, dividing to provide new nuclei for muscle fibre repair and growth. Their survival is essential for muscle regeneration; their depletion during prolonged denervation limits the muscle's capacity for recovery.

Schwann cells (Tier 1) The glial cells of the peripheral nervous system that wrap around nerve fibres to form the myelin sheath. Following nerve injury, Schwann cells play a critical role in the repair process: they clear debris from the damaged nerve, form physical guides (bands of Bungner) for regrowing axons, and release growth-promoting factors. Their capacity to support regeneration declines with prolonged denervation.

Z-disc (Tier 2) A structural boundary within the sarcomere that anchors the actin filaments. Z-disc alignment is a marker of healthy sarcomere organisation; its disruption is a sign of denervation-related structural damage, and its restoration indicates successful treatment.

C. Molecular Biology and Signalling

Autophagy (Tier 2) A cellular housekeeping process in which damaged or unnecessary components are enclosed within membranes and broken down for recycling. In denervated muscle, autophagy contributes to the degradation of contractile proteins alongside the ubiquitin-proteasome system.

BDNF (brain-derived neurotrophic factor) (Tier 2) A protein produced by nerve cells and Schwann cells that promotes the survival, growth, and regeneration of neurons. Brief electrical stimulation applied to a nerve during surgery increases BDNF production, which is one of the mechanisms by which this intervention accelerates nerve regeneration.

cAMP (cyclic adenosine monophosphate) (Tier 2) A signalling molecule within cells that acts as a messenger, triggering a cascade of biological responses. In the context of nerve regeneration, brief electrical stimulation increases cAMP levels in nerve cells, which in turn promotes the production of growth factors such as BDNF.

FGF-1 / FGF-2 (fibroblast growth factors) (Tier 3) Proteins that stimulate cell growth, wound healing, and blood vessel formation. They play a role in the tissue repair processes relevant to both wound healing and muscle regeneration.

FOXO3a / FoxO3 (Tier 3) A transcription factor that activates genes responsible for muscle protein degradation. In denervated muscle, FOXO3a drives the expression of the ubiquitin ligases MuRF1 and MAFbx, accelerating the breakdown of contractile proteins.

GAP-43 (Tier 3) Growth-associated protein 43 — a protein found at the tips of growing nerve fibres. Its production increases during nerve regeneration and is used as a marker of active axonal growth.

IGF-1 (insulin-like growth factor 1) (Tier 3) A growth-promoting protein released during muscle contraction that supports muscle repair and growth. Its production is one mechanism by which electrical stimulation helps maintain muscle tissue.

IL-6 (interleukin-6) (Tier 3) A signalling protein involved in inflammation and tissue remodelling. In denervated muscle, elevated IL-6 levels contribute to the activation of fibro-adipogenic progenitor cells, promoting the replacement of muscle by fat and scar tissue.

MCP-1 / CCL2 (Tier 3) A chemokine — a small signalling protein that attracts immune cells to a site of injury. MCP-1 recruits macrophages to a damaged nerve, which is essential for clearing debris during Wallerian degeneration.

MuRF1 / MAFbx (atrogin-1) (Tier 3) Two muscle-specific ubiquitin ligases — enzymes that tag contractile proteins for destruction by the ubiquitin-proteasome system. Their activity is dramatically increased in denervated muscle, driving the rapid loss of muscle protein.

NAD+ (nicotinamide adenine dinucleotide) (Tier 3) A molecule essential for cellular energy production. In nerve biology, the balance between NAD+ production (by NMNAT2) and NAD+ destruction (by SARM1) acts as a molecular switch that determines whether a severed axon survives or degenerates.

Netrins, semaphorins, ephrins, Slit/Robo (Tier 3) Families of molecular guidance cues that direct the growth of regenerating nerve fibres. These molecules provide chemical signals — some attracting and some repelling — that help regrowing axons navigate toward their correct targets.

Neuregulin / ErbB2 signalling (Tier 3) A molecular signalling system that Schwann cells use to detect nerve injury. Changes in neuregulin signalling trigger Schwann cells to switch from their normal insulating role to their repair role, initiating the debris clearance and guidance functions essential for nerve regeneration.

Neurotrophic factors (Tier 1) Proteins produced by nerve cells, Schwann cells, and target tissues that promote the survival, growth, and function of neurons. Key neurotrophic factors include BDNF, GDNF, and NGF. Their production by Schwann cells declines with prolonged denervation, reducing the capacity for nerve regeneration.

PGC-1alpha (Tier 3) A protein that regulates genes involved in energy metabolism and mitochondrial function in muscle. Sometimes called the "endurance switch," PGC-1alpha is downregulated in denervated muscle, contributing to the shift from slow, fatigue-resistant fibres toward fast, fatigable fibres.

PI3K / PTEN signalling (Tier 3) Intracellular signalling pathways that regulate cell migration and growth. In wound healing, these pathways mediate the directional migration of skin cells in response to electrical fields.

STAT3-IL-6 signalling (Tier 3) A molecular signalling pathway activated in denervated muscle that promotes the conversion of muscle tissue to fat. STAT3 is a protein that transmits the signal from IL-6 into the cell nucleus, where it alters gene expression.

Transcription factor (Tier 2) A protein that binds to DNA and controls the activity of specific genes — switching them on or off. In the context of denervation, transcription factors such as FOXO3a activate genes that drive muscle protein breakdown, while c-Jun activates genes that convert Schwann cells into their repair state.

trkB (Tier 3) The receptor protein on nerve cells that responds to BDNF (brain-derived neurotrophic factor). When BDNF binds to trkB, it triggers the signalling cascades that promote nerve survival and growth.

Ubiquitin-proteasome system (Tier 2) The primary mechanism by which cells break down unwanted or damaged proteins. Proteins are tagged with a small molecule called ubiquitin, which marks them for destruction by a cellular structure called the proteasome. In denervated muscle, this system is abnormally active, driving the rapid loss of contractile proteins.

Ubiquitin ligase (Tier 3) An enzyme that attaches ubiquitin tags to proteins, marking them for destruction. The muscle-specific ubiquitin ligases MuRF1 and MAFbx are dramatically upregulated in denervated muscle.

VEGF / VEGF-A (vascular endothelial growth factor) (Tier 3) A protein that stimulates the formation of new blood vessels (angiogenesis). In wound healing, VEGF promotes the growth of blood supply into the wound bed. In nerve regeneration, it supports the vascularisation needed to sustain regrowing nerve tissue.

D. Electrical Stimulation and Device Terminology

Accommodation (neurophysiological) (Tier 2) The ability of intact nerve fibres to adjust their excitability threshold when current rises gradually, effectively keeping pace with the rising current and avoiding activation. Denervated muscle fibres cannot accommodate, which means a slowly rising (triangular) waveform can selectively activate denervated fibres while leaving intact nerves unaffected. This principle is clinically useful in mixed presentations where denervated and innervated muscles coexist.

Biphasic (waveform) (Tier 1) A waveform in which each pulse consists of two phases — one positive and one negative. Biphasic pulses ensure charge balance, preventing the accumulation of electrochemical products at the electrode-skin interface that could cause tissue damage. Most medical-grade stimulators for denervated muscle use biphasic waveforms.

Carbon rubber electrodes (Tier 2) Reusable electrodes made from a flexible rubber material impregnated with carbon particles to make it electrically conductive. Used with wet sponge covers, they provide the large electrode surface areas needed for denervated muscle stimulation.

Cathodal / anodal (Tier 3) Relating to the cathode (negative electrode) or anode (positive electrode) respectively. In some stimulation protocols, the polarity of the electrode placed over the treatment area is specified because current flow direction can influence the biological response, particularly in wound healing.

Charge balance / charge-balanced (Tier 1) The principle that the net electrical charge delivered to the tissue over time is zero — the positive phase of a biphasic pulse delivers the same total charge as the negative phase. Charge balance prevents the accumulation of electrochemical by-products at the electrode-skin interface, protecting against chemical burns and tissue damage.

Chronaxie (Tier 1) The minimum pulse duration needed to stimulate a tissue when the current is set at twice the rheobase. Chronaxie provides a single-number summary of a tissue's electrical excitability. In innervated muscle, chronaxie is typically less than one millisecond; in denervated muscle, it may be ten to one hundred times longer. Tracking chronaxie over time is one of the most specific clinical indicators of denervation severity and treatment response.

Current-controlled vs voltage-controlled (Tier 2) Two approaches to delivering electrical stimulation. A current-controlled device regulates the current flowing through the tissue, automatically adjusting the voltage to compensate for changes in tissue impedance. A voltage-controlled device sets the voltage and allows the current to vary. Current-controlled delivery ensures consistent stimulation regardless of factors such as electrode contact, skin moisture, and tissue composition, and is mandatory for safe denervated muscle stimulation.

Current density (Tier 2) The amount of electrical current flowing through a given area of tissue, expressed as milliamperes per square centimetre (mA/cm²). Higher current density increases the risk of skin irritation or burns. Using larger electrodes distributes the same total current over a greater area, reducing current density and improving safety.

Dispersive electrode (Tier 3) The return or inactive electrode in a stimulation circuit, placed away from the treatment site. Its purpose is to complete the electrical circuit. A dispersive electrode is typically larger than the active electrode to keep current density low at its site.

Duty cycle (Tier 2) The ratio of stimulation time to rest time within a treatment session, usually expressed as a percentage or a ratio (e.g., 4 seconds on, 4 seconds off = 50% duty cycle). The duty cycle determines the balance between muscle work and recovery, and is adjusted as the muscle's endurance improves.

Electrochemical burn / damage (Tier 3) Tissue damage caused by chemical by-products that accumulate at the electrode-skin interface when electrical charge is not balanced. Charge-balanced biphasic waveforms prevent this by ensuring that no net charge accumulates.

EMG-triggered stimulation (Tier 2) A mode in which the stimulator detects residual voluntary muscle activity using electromyography (EMG) sensors, and then supplements it with electrical stimulation. This approach is useful in partially reinnervated muscles, where some voluntary control is returning but is not yet sufficient to produce functional movement.

FES (functional electrical stimulation) (Tier 1) The application of electrical stimulation to produce functional movement — for example, activating leg muscles to pedal a bicycle or to support standing. FES works through the intact motor nerves and is distinct from the specialised stimulation of denervated muscle, which bypasses the absent nerve and stimulates the muscle fibre directly.

Hz (Hertz) (Tier 3) The unit of frequency, equal to one cycle or pulse per second. In electrical stimulation, frequency determines whether the muscle produces individual twitches (low frequency, typically 1–5 Hz) or a sustained, fused contraction (higher frequency, typically above 20 Hz).

Impedance (Tier 1) The opposition that a tissue presents to the flow of electrical current, measured in ohms. Impedance varies with tissue type, electrode contact quality, skin moisture, and stimulation frequency. Current-controlled stimulators compensate for impedance changes automatically; voltage-controlled devices do not, leading to unpredictable stimulation.

mA (milliamperes) (Tier 3) A unit of electrical current equal to one thousandth of an ampere. Stimulation intensity for denervated muscle typically ranges from 50 to 250 mA, depending on the size of the muscle and the depth of the target tissue.

Monophasic waveform (Tier 3) A waveform in which current flows in one direction only. Because monophasic waveforms are not charge-balanced, they carry a higher risk of electrochemical damage and are generally avoided for prolonged stimulation of denervated muscle. High-voltage pulsed current for wound healing is one exception, where the brief pulse duration limits the total charge delivered.

Pulse width / pulse duration (Tier 2) The duration of each individual electrical pulse, measured in milliseconds. Pulse width is one of the most critical parameters distinguishing denervated from innervated muscle stimulation. Standard neuromuscular stimulation uses pulse widths below one millisecond; denervated muscle requires pulse widths of tens to hundreds of milliseconds because the muscle fibre membrane, lacking the amplification of the neuromuscular junction, needs a much longer pulse to reach the depolarisation threshold.

Rheobase (Tier 1) The minimum current intensity needed to stimulate a tissue when the pulse duration is infinitely long. In practice, rheobase is measured by progressively increasing the pulse duration until no further reduction in the threshold current is observed. Rheobase and chronaxie together define the tissue's strength-duration curve.

SDSS (spatially distributed sequential stimulation) (Tier 3) A stimulation technique in which current is delivered through multiple electrodes in a rotating sequence rather than simultaneously. This distributes the stimulation across different areas of the muscle, potentially reducing fatigue and more closely mimicking the natural pattern of motor unit recruitment.

Tetanic contraction (Tier 1) A smooth, sustained muscle contraction produced when stimulation pulses are delivered at a frequency high enough that individual twitches fuse together. In innervated muscle, this occurs above approximately 20 Hz. Tetanic contractions represent the goal of the later phases of the Vienna protocol, as they produce the sustained mechanical loading needed for genuine muscle strengthening.

E. Medical Conditions and Clinical Terms

Amyotrophic lateral sclerosis (ALS) (Tier 3) A progressive neurological disease in which both upper and lower motor neurons degenerate, leading to progressive muscle weakness, wasting, and paralysis. Also known as motor neurone disease in the UK.

Autonomic dysreflexia (Tier 2) A potentially dangerous condition affecting people with spinal cord injuries at or above the sixth thoracic vertebra (T6), in which a stimulus below the level of injury triggers an uncontrolled rise in blood pressure. Symptoms include severe headache, facial flushing, sweating above the level of injury, and slow heart rate. It is a medical emergency that can be triggered by electrical stimulation, overfull bladder, or constipation, among other causes.

Bell's palsy (Tier 2) The most common cause of facial paralysis, thought to be caused by viral inflammation of the facial nerve within its bony canal in the skull. Most cases resolve spontaneously, but approximately 30 per cent of patients experience incomplete recovery.

Bradycardia (Tier 3) An abnormally slow heart rate, typically below 60 beats per minute. Bradycardia can be a symptom of autonomic dysreflexia in people with spinal cord injuries.

Comorbidities (Tier 3) Other medical conditions that a person has in addition to the primary condition being treated. Comorbidities may affect treatment decisions, the choice of stimulation parameters, and the likelihood of achieving treatment goals.

Complex regional pain syndrome (CRPS) (Tier 3) A chronic pain condition that can develop after nerve injury, characterised by severe, burning pain, swelling, skin colour changes, and temperature abnormalities in the affected limb. The pain is disproportionate to the original injury.

Deep vein thrombosis (DVT) (Tier 3) A blood clot that forms in one of the deep veins, usually in the leg. DVT is a contraindication for electrical stimulation of the affected area because stimulation-induced muscle contraction could theoretically dislodge the clot.

Drop foot / foot drop (Tier 2) The inability to lift the front part of the foot during walking, causing the toes to drag on the ground. Drop foot results from damage to the common peroneal nerve or the motor neurons supplying the tibialis anterior muscle.

Guillain-Barré syndrome (Tier 3) An autoimmune condition in which the body's immune system attacks the peripheral nerves, causing rapidly progressive weakness that can lead to paralysis. Recovery is possible but may leave residual denervation.

Hemiplegia / hemiplegic (Tier 3) Paralysis of one side of the body, typically resulting from stroke or brain injury. Hemiplegia involves upper motor neuron damage — the lower motor neurons remain intact, and the muscles retain their nerve supply.

Iatrogenic (Tier 3) Caused by medical treatment. Iatrogenic nerve damage refers to nerve injury that occurs as an unintended consequence of surgery, such as damage to the recurrent laryngeal nerve during thyroid surgery or to the peroneal nerve during knee replacement.

Ischaemia / ischaemic (Tier 2) A reduction in blood supply to a tissue, resulting in a shortage of oxygen and nutrients. Sustained pressure on tissue causes ischaemia, which is the primary mechanism by which pressure ulcers develop.

Malignancy (Tier 3) Cancer. Active malignancy at or near the treatment site is a contraindication for electrical stimulation because the growth-promoting effects of stimulation could theoretically accelerate tumour growth.

Multiple sclerosis (Tier 3) A chronic autoimmune disease in which the immune system attacks the myelin sheath of nerve fibres in the brain and spinal cord. Multiple sclerosis causes upper motor neuron damage, and the muscles typically retain their nerve supply.

Neuropathic pain (Tier 1) Pain caused by damage to or disease of the nerve itself, rather than by tissue injury. Neuropathic pain is often described as burning, shooting, or electric-shock-like, and it is a common consequence of nerve injury, spinal cord injury, and brachial plexus damage. It differs from ordinary pain in that it persists in the absence of ongoing tissue damage and responds poorly to standard painkillers.

Oedema (Tier 2) Swelling caused by the accumulation of excess fluid in the tissues. Oedema around a damaged nerve can compress the nerve fibres, worsening the injury. In chronic wounds, oedema impairs healing by reducing oxygen and nutrient delivery.

Osteoporosis (Tier 2) A condition in which bones become thinner and more fragile due to loss of mineral density. In people with spinal cord injuries, osteoporosis develops rapidly in the paralysed limbs because the bones are no longer loaded by muscle contraction and weight-bearing.

Osteomyelitis (Tier 3) An infection of bone. Osteomyelitis is a risk in deep pressure ulcers that extend to the bone, particularly over the sitting bones and the base of the spine. It must be treated before electrical stimulation for wound healing is applied.

Paraplegia / paraplegic (Tier 1) Paralysis of the lower limbs and, depending on the level of injury, the trunk, resulting from damage to the spinal cord. The term does not specify whether the paralysis involves upper motor neuron damage, lower motor neuron damage, or both.

Phlebitis (Tier 3) Inflammation of a vein, often associated with a blood clot. Active phlebitis is a contraindication for electrical stimulation of the affected area.

Poliomyelitis / polio (Tier 3) A viral disease that destroys the lower motor neurons in the spinal cord, causing permanent denervation and paralysis of the muscles those neurons supply. Polio was a major cause of denervation before widespread vaccination.

Pressure ulcers / pressure injuries (Tier 2) Areas of tissue damage caused by sustained pressure, typically over bony prominences, that restricts blood flow to the skin and underlying tissue. In people with spinal cord injuries, reduced sensation, impaired circulation, and loss of the protective muscle bulk that normally cushions the bones all increase the risk. Pressure ulcers range from superficial skin damage to deep wounds involving muscle and bone.

Spasticity (Tier 1) A condition resulting from upper motor neuron damage in which muscles become abnormally stiff and resistant to movement, often with involuntary spasms. Spasticity occurs because the lower motor neurons, no longer properly regulated by the brain, become overactive. It affects 65–75 per cent of people with spinal cord injuries and can interfere with rehabilitation, positioning, and daily activities.

Spinal cord injury (Tier 2) Damage to the spinal cord that disrupts the transmission of signals between the brain and the body. The consequences depend on the level and completeness of the injury and may include paralysis, loss of sensation, and disruption of bladder, bowel, and cardiovascular function.

Tetraplegia (Tier 1) Paralysis of all four limbs, resulting from damage to the spinal cord in the neck (cervical region). Also known as quadriplegia.

F. Measurement, Imaging, and Diagnostic Techniques

Biopsy / muscle biopsy (Tier 1) A procedure in which a small sample of tissue is removed for examination under a microscope. In the denervated muscle research, muscle biopsies provided the most detailed evidence of treatment effects — showing changes in fibre size, fibre type, fat content, and the restoration of the contractile machinery at a level of detail not possible with any imaging technique.

Compound muscle action potential (Tier 3) The electrical signal recorded from a muscle when the nerve supplying it is stimulated. The amplitude of this signal reflects the number of functioning motor units. In electroneurography (ENoG) of the facial nerve, comparing the compound muscle action potential on the paralysed and normal sides provides a measure of the severity of nerve damage.

Correlation coefficient (Tier 3) A statistical measure of the strength and direction of the relationship between two variables, ranging from -1 (perfect negative relationship) to +1 (perfect positive relationship). A correlation coefficient close to 1 indicates that two measurements are strongly related.

Creatine kinase (Tier 3) An enzyme found in muscle cells that is released into the blood when muscle fibres are damaged. Elevated creatine kinase levels in blood tests can indicate muscle damage, including the muscle fibre breakdown that can occur during the early phases of electrical stimulation.

Cross-sectional area (CSA) (Tier 1) A measurement of the size of a muscle as seen in a slice taken perpendicular to the limb — typically obtained from CT or MRI scans. Cross-sectional area is the primary outcome measure in the denervated muscle research because it directly reflects how much functional muscle tissue remains.

CT / computed tomography (Tier 2) An imaging technique that uses X-rays taken from multiple angles to produce detailed cross-sectional images of the body. In the denervated muscle research, CT scans provided the primary means of measuring muscle cross-sectional area and distinguishing functional muscle tissue from fat infiltration.

Dynamometry / dynamometers (Tier 3) The measurement of force or torque using calibrated instruments. Dynamometers can measure the force produced by a muscle contraction, providing a quantitative indicator of muscle strength.

Electron microscopy (Tier 3) An imaging technique that uses beams of electrons instead of light to produce images at extremely high magnification, revealing structures too small for conventional microscopes. In the denervated muscle research, electron microscopy confirmed the restoration of sarcomere organisation and triadic junctions at the molecular level.

EMG / electromyography (Tier 1) A diagnostic technique that records the electrical activity of muscles. A needle electrode is inserted into the muscle to detect signals such as fibrillation potentials (indicating active denervation) and motor unit potentials (indicating intact or recovering nerve supply). EMG is the most direct method for confirming denervation and monitoring reinnervation.

Fascicle length (Tier 3) The length of individual muscle fibre bundles as measured on ultrasound. Changes in fascicle length can indicate changes in muscle architecture resulting from denervation or treatment.

Girth measurements (Tier 3) Measurements of the circumference of a limb at standardised points, taken with a tape measure. While less precise than imaging, serial girth measurements provide a simple, inexpensive way to track changes in muscle bulk over time.

Hounsfield unit (Tier 3) A unit of measurement used in CT scanning that indicates the density of tissue. Different tissues have characteristic Hounsfield values — muscle, fat, and bone can be distinguished and quantified, allowing researchers to measure the proportion of functional muscle tissue within a limb cross-section.

Inertial measurement units (Tier 3) Small electronic sensors that detect movement and orientation, combining accelerometers and gyroscopes. In rehabilitation, wearable inertial measurement units can objectively track limb movement and the quality of muscle contractions during treatment sessions.

MRI T2 mapping (Tier 3) A specialised magnetic resonance imaging technique that measures the T2 relaxation time of tissues, providing information about tissue composition. In muscle assessment, T2 mapping can detect oedema, inflammation, and fat infiltration non-invasively.

Motor unit number estimation (MUNE) (Tier 3) An electrophysiological technique that estimates the number of functioning motor units in a muscle. MUNE provides a quantitative measure of the extent of denervation and can track reinnervation over time.

Near-infrared spectroscopy (NIRS) (Tier 3) A non-invasive technique that measures tissue oxygenation by shining near-infrared light through the skin and detecting the different absorption patterns of oxygenated and deoxygenated haemoglobin. NIRS can provide real-time information about muscle oxygen consumption during stimulation.

Nerve conduction studies (Tier 2) Diagnostic tests that measure the speed and strength of electrical signals travelling along a nerve. An electrical stimulus is applied to the nerve at one point, and the resulting signal is recorded at another. Slow conduction speed or absent signals indicate nerve damage.

Pennation angle (Tier 3) The angle at which muscle fibres insert into the tendon, as measured on ultrasound. The pennation angle reflects muscle architecture and can change in response to denervation, atrophy, and treatment.

Phosphorus magnetic resonance spectroscopy (Tier 3) An imaging technique that measures the concentration of phosphorus-containing compounds in tissue, providing information about cellular energy metabolism. It can assess whether a muscle's metabolic capacity is responding to treatment.

Tinel sign (Tier 3) A clinical test for nerve regeneration in which the clinician taps along the course of a nerve. A tingling sensation felt in the nerve's distribution indicates the presence of regenerating nerve fibres at that point. An advancing Tinel sign — the tingling point moving progressively further from the injury site — indicates active nerve regrowth.

G. Research Methodology and Statistics

Cochrane review (Tier 2) A systematic review produced by the Cochrane Collaboration — an international network of researchers who use standardised methods to summarise the best available evidence on health interventions. Cochrane reviews are widely regarded as the highest standard of evidence synthesis.

Confidence interval (Tier 3) A range of values within which the true effect is likely to fall, calculated from study data. A 95% confidence interval means that there is a 95% probability that the true value lies within the stated range. Narrower intervals indicate more precise estimates.

Correlation coefficient (Tier 3) See entry under F. Measurement, Imaging, and Diagnostic Techniques.

Cost-effectiveness / cost-dominant (Tier 2) A health economic analysis that compares the costs and health outcomes of different treatments. A treatment is cost-effective if it produces better outcomes for an acceptable additional cost. A treatment is cost-dominant if it produces better outcomes at lower overall cost — saving money while improving results.

Cross-sectional study (Tier 3) A study design that examines a group of people at a single point in time, providing a snapshot rather than tracking changes over time. Cross-sectional studies can identify associations but cannot determine whether one factor causes another.

Double-blind (Tier 2) A study design in which neither the participants nor the clinicians assessing the outcomes know who is receiving the active treatment and who is receiving the sham or placebo. Double-blinding minimises the risk that expectations or beliefs will influence the results.

Effect size (Tier 2) A statistical measure of the magnitude of a treatment effect — how large the difference is between the treatment and control groups. A larger effect size indicates a more meaningful clinical difference, regardless of whether the result is statistically significant.

GRADE framework (Tier 2) Grading of Recommendations, Assessment, Development, and Evaluations — a standardised system for rating the certainty of evidence and the strength of clinical recommendations. GRADE ratings range from very low to high certainty, and are used by guideline panels worldwide to translate research evidence into clinical guidance.

Heterogeneity (study) (Tier 3) The degree of variation between the results of different studies included in a systematic review or meta-analysis. High heterogeneity suggests that the studies may not be directly comparable — because of differences in the populations, interventions, or outcome measures used — and that a single overall summary may be misleading.

Interrater reliability / agreement (Tier 3) A measure of how consistently different clinicians or assessors produce the same result when evaluating the same patient or measurement. High interrater reliability means the measurement is reproducible regardless of who performs it.

Kappa coefficient (Tier 3) A statistical measure of agreement between two assessors that accounts for the possibility of agreement occurring by chance. A kappa value above 0.80 is generally considered excellent agreement.

Level I evidence (Tier 3) The highest level in evidence hierarchies, typically derived from well-designed randomised controlled trials or systematic reviews of such trials. Level I evidence provides the strongest basis for clinical recommendations.

Longitudinal study (Tier 3) A study design that follows the same individuals over an extended period, measuring changes over time. Longitudinal studies can track the natural course of a condition or the effects of treatment as they develop.

Meta-analysis (Tier 1) A statistical method that combines the results of multiple independent studies to produce a single, more precise estimate of a treatment's effect. By pooling data from many studies, a meta-analysis can detect effects that individual studies may be too small to identify and can provide a more reliable overall summary of the evidence.

Natural history (clinical) (Tier 3) The expected course of a disease or condition over time without treatment. Understanding the natural history of denervated muscle — progressive atrophy, fat infiltration, and loss of regenerative capacity — is essential for evaluating whether treatment produces outcomes that differ from what would happen without intervention.

Prospective study (Tier 2) A study design in which participants are enrolled and then followed forward in time, with outcomes measured as they occur. Prospective studies are generally considered more reliable than retrospective studies because data are collected before the outcome is known.

QALY (quality-adjusted life year) (Tier 2) A measure used in health economics that combines the length of life with its quality, where one QALY equals one year of life in perfect health. QALYs allow the comparison of treatments that produce different types of benefit — for example, a treatment that modestly extends life versus one that significantly improves quality of life.

Randomised controlled trial (RCT) (Tier 1) A study design in which participants are randomly assigned to receive either the treatment being tested or a comparison (such as a sham treatment or standard care). Randomisation minimises the risk that differences between groups — rather than the treatment itself — explain any observed effects. RCTs are considered the most reliable way to determine whether a treatment works.

Risk ratio (Tier 3) A measure that compares the probability of an outcome in the treatment group with the probability in the control group. A risk ratio of 0.65 for incomplete recovery, for example, means that the treatment group was 35% less likely to experience incomplete recovery than the control group.

Sensitivity (diagnostic) (Tier 3) The proportion of people who genuinely have a condition who are correctly identified by a test. A test with 90% sensitivity correctly identifies 90 out of every 100 people who have the condition, missing 10.

Sham-controlled / sham stimulation (Tier 2) A control condition in which participants undergo a procedure that appears identical to the real treatment — electrodes are applied, the device is turned on — but no therapeutic stimulation is delivered. Sham controls allow researchers to determine whether the observed effects are due to the stimulation itself rather than to the placebo effect or the attention of being in a study.

Standardised mean difference (Tier 3) A statistical measure used to compare results across studies that use different measurement scales. It expresses the difference between the treatment and control groups in terms of the variability within the groups, allowing effects measured in different units to be compared directly.

Strength of Evidence A (Tier 3) The highest rating in clinical practice guideline systems, indicating that the recommendation is supported by strong evidence — typically from multiple well-designed randomised controlled trials.

Systematic review (Tier 2) A research method that uses a predefined, transparent strategy to identify, evaluate, and summarise all available evidence on a specific clinical question. Unlike a narrative review, which selects studies at the author's discretion, a systematic review aims to minimise bias by comprehensively searching the literature and applying explicit criteria for including and evaluating studies.

H. Wound Healing

Angiogenesis (Tier 2) The formation of new blood vessels from existing ones. Angiogenesis is essential for wound healing because it delivers the oxygen and nutrients that the healing tissue requires. Electrical stimulation has been shown to promote angiogenesis in wound beds.

Biofilm (Tier 2) A structured community of bacteria embedded in a protective matrix that adheres to the wound surface. Biofilms are estimated to be present in 60–90% of chronic wounds and are a major reason why these wounds resist healing. The protective matrix makes the bacteria within a biofilm far more resistant to antibiotics than free-floating bacteria.

Debridement (Tier 2) The removal of dead, damaged, or infected tissue from a wound to promote healing. Debridement is a prerequisite for electrical stimulation treatment, as dead tissue and debris impair both the wound's electrical signals and its capacity to heal.

Endothelial cells (Tier 3) The cells that line the inside of blood vessels. In wound healing, endothelial cells migrate toward the wound bed and divide to form new blood vessels (angiogenesis), restoring the blood supply needed for tissue repair.

Epidermis (Tier 2) The outermost layer of the skin, which provides a physical and chemical barrier against the environment. The epidermis contains the ion pumps that generate the transepithelial potential — the "skin battery" described in Chapter 18.

Eschar (Tier 3) A thick, dark, leathery scab of dead tissue that forms over some wounds. Eschar must typically be removed (debrided) before wound healing can progress and before electrical stimulation is applied.

Fibroblasts (Tier 2) Connective tissue cells responsible for producing collagen and other structural proteins. In wound healing, fibroblasts migrate into the wound bed, build the structural scaffolding for new tissue, and eventually contract to reduce the wound size.

Granulation tissue (Tier 3) The new, pink, bumpy tissue that forms in a healing wound, composed of new blood vessels, fibroblasts, and connective tissue. Healthy granulation tissue is a sign that healing is progressing.

Hyperkeratotic (Tier 3) Abnormally thickened skin. The rolled, hyperkeratotic edges often seen at the margins of chronic wounds may act as a barrier to cell migration and wound closure.

Hypoalbuminaemia (Tier 3) An abnormally low level of albumin — a protein — in the blood, indicating poor nutritional status. Hypoalbuminaemia is common in people with spinal cord injuries and is independently associated with impaired wound healing.

Keratinocytes (Tier 2) The principal cells of the epidermis, responsible for forming the skin's protective barrier. In wound healing, keratinocytes migrate from the wound edges toward the centre, guided by the wound's electrical field, to close the wound — a process called re-epithelialisation.

Macrophages (Tier 3) Immune cells that engulf and digest cellular debris, bacteria, and damaged tissue. In wound healing, macrophages clear the wound bed and release signalling molecules that coordinate the repair process.

Perfusion (Tier 2) The flow of blood through the small vessels (capillaries) of a tissue. Adequate perfusion delivers oxygen and nutrients and removes waste products. Impaired perfusion — caused by sustained pressure, denervation, or vascular disease — is a primary reason why chronic wounds fail to heal.

Re-epithelialisation (Tier 3) The process by which skin cells (keratinocytes) grow inward from the wound margins to cover the wound surface with new epidermis, closing the wound. The wound's electrical field is the dominant directional signal guiding this migration.

Stratum granulosum (Tier 3) A layer within the epidermis where the ion pumps that generate the skin's transepithelial potential are concentrated. The tight junctions between cells in this layer prevent ions from leaking back, maintaining the voltage difference that drives the wound's electrical healing signal.

Tight junctions (Tier 3) Specialised connections between adjacent cells that create a seal, preventing ions and molecules from passing between them. In the epidermis, tight junctions are essential for maintaining the transepithelial potential by preventing the ions pumped by the skin's biological battery from simply leaking back.

Wound exudate (Tier 3) Fluid that seeps from a wound, consisting of blood plasma, inflammatory cells, and tissue debris. In chronic wounds, excessive exudate creates a highly conductive environment that can short-circuit the wound's electrical healing signal.

I. Regulatory and Standards

Bias (AI context) (Tier 3) Systematic errors in an artificial intelligence system's outputs that result from biased training data, flawed assumptions, or inadequate representation of different populations. The EU AI Act requires that AI systems used in medical devices identify and mitigate such bias.

Conformity assessment (Tier 3) The process by which a medical device manufacturer demonstrates that their product meets the requirements of the applicable regulations. Conformity assessment may involve testing, inspection, certification, and quality system audits, depending on the device's risk classification.

Derogations (regulatory) (Tier 3) Exemptions or relaxations of regulatory requirements, typically granted on a time-limited basis. Medical professional organisations have called for derogations for specialist devices at risk of market withdrawal due to the cost of compliance with newer regulations.

Electrical isolation (Tier 3) A safety design feature that prevents dangerous electrical currents from reaching the patient in the event of a device fault. Electrical isolation is mandatory under the IEC 60601 safety standard for medical electrical equipment.

Machine learning (Tier 3) A type of artificial intelligence in which a system learns from data and improves its performance over time without being explicitly programmed for each decision. Medical devices that incorporate machine learning — such as adaptive stimulation systems that adjust parameters based on patient responses — must comply with both medical device regulations and the EU AI Act.

Protective earthing (Tier 3) A safety measure in which the conductive parts of a medical device that could become live in the event of a fault are connected to earth (ground), providing a safe path for fault currents to flow away from the patient.

J. Historical and Named Terms

Eccentric contraction (Tier 2) A type of muscle contraction in which the muscle lengthens while generating force — for example, lowering a weight slowly. Eccentric contractions generate more force than concentric (shortening) contractions but can cause more muscle fibre damage, which is relevant to understanding the muscle soreness sometimes reported during early phases of electrical stimulation.

Faradism / faradic pulse (Tier 3) A historical term for the brief, alternating electrical pulses produced by an induction coil, as distinct from the steady direct current of a galvanic battery. Faradic stimulation was used in early rehabilitation to stimulate muscles through their motor nerves. The distinction between faradic and galvanic stimulation was clinically important in the 19th and early 20th centuries and prefigures the modern distinction between nerve stimulation and direct muscle fibre stimulation.

Galvanic current (Tier 3) A historical term for steady, direct electrical current produced by a chemical battery. Named after Luigi Galvani, whose 1791 experiments with frog legs launched the study of bioelectricity. Galvanic current was used in early attempts to stimulate denervated muscle, though it carried risks of electrochemical burns because it was not charge-balanced.

Habilitation thesis (Tier 3) A postdoctoral academic qualification required for professorship in several European countries, involving a substantial body of original research. In the context of this book, the habilitation theses of key researchers document the foundational evidence for electrical stimulation of denervated muscle.

Swing phase of gait (Tier 3) The portion of the walking cycle during which the foot is off the ground and the leg is swinging forward. The first functional electrical stimulation device — Liberson's peroneal nerve stimulator of 1961 — was designed to activate the foot-lifting muscles during the swing phase, correcting drop foot.